Safety & Efficacy of Pilocarpine Eye Solutions for Temporary Improvement of Near Vision in Presbyopic Adults

Primary Inclusion Criteria: * Poor near vision impacting daily living that requires near correction * Best-corrected distance visual acuity (BCDVA) of 0.0 logMar or better * Manifest refraction spherical equivalent ≥ -2.00 Diopters (D) and ≤ +2.00 D * Monocular DCNVA between 0.4 and 0.7 logMAR, inclusive Primary Exclusion Criteria: * Diagnosis of glaucoma or ocular hypertension * Narrow iridocorneal angles * History of intraocular surgery, refractive surgery, laser treatment, or iris surgery * Clinically significant abnormality of cornea, lens, retina, ciliary body, or iris * Presence/history of a severe/serious ocular condition or any other unstable medical condition * Presence or history of manifest strabismus, amblyopia, or nystagmus * Current active eye disease for which topical or systemic ophthalmic medication is necessary, except for dry eye syndrome managed using artificial tears * Clinically significant external ocular inflammation within 30 days of Screening Visit * Current use or history of rigid gas permeable (RGP) contact lens use within 30 days of Screening Visit * Known pilocarpine allergy or contraindication to use of pilocarpine * Presence or history of congenital heart anomaly, valve disease, or other cardiac disease * Disabling arthritis or limited motor coordination that would limit the subject's ability to self-administer study solution using the Optejet